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Abstract
Background: Ninety percent of cases of diabetes are of the slowly evolving non-insulin-dependent
type, or Type 2 diabetes. Lack of exercise is regarded as one of the main causes of this disorder.
In this study we analyzed the effects of physical exercise on glucose homeostasis in adult rats with
type 2 diabetes induced by a neonatal injection of alloxan.
Methods: Female Wistar rats aged 6 days were injected with either 250 mg/kg of body weight of
alloxan or citrate buffer 0.01 M (controls). After weaning, half of the animals in each group were
subjected to physical training adjusted to meet the aerobic-anaerobic metabolic transition by
swimming 1 h/day for 5 days a week with weight overloads. The necessary overload used was set
and periodically readjusted for each rat through effort tests based on the maximal lactate steady
state procedure. When aged 28, 60, 90, and 120 days, the rats underwent glucose tolerance tests
(GTT) and their peripheral insulin sensitivity was evaluated using the HOMA index.
Results: The area under the serum glucose curve obtained through GTT was always higher in
alloxan-treated animals than in controls. A decrease in this area was observed in trained alloxan-
treated rats at 90 and 120 days old compared with non-trained animals. At 90 days old the trained
controls showed lower HOMA indices than the non-trained controls.
Conclusion: Neonatal administration of alloxan induced a persistent glucose intolerance in all
injected rats, which was successfully counteracted by physical training in the aerobic/anaerobic
metabolic transition.
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Background
Diabetes mellitus is caused by the reduced secretion and/
or diminished action of insulin. Diabetic individuals fall
into two distinct groups, those in which the disease is
caused by a lack of insulin – known as insulin-dependent
diabetes mellitus or IDDM – or by a certain resistance to
the action of insulin, known as non-insulin-dependent
diabetes mellitus or NIDDM.
NIDDM develops in a slow and delayed manner, and
accounts for about 90% of the cases of diabetes. The main
causes of type 2 diabetes include obesity, high calorie
intake and a sedentary lifestyle [1].
Insulin resistance inhibits glucose consumption by mus-
cles and adipose tissues, and stimulates glucose release by
the liver, leading to hyperglycemia. There is evidence that
insulin resistance may be the first derangement in cases of
diabetes, preceding the onset of hyperglycemia [2].
In 1989, Portha et al. developed an experimental model
for testing insulin resistance by administering streptozo-
tocin to newly born rats. This caused transitory hyperglyc-
emia in the rats, with basal serum glucose levels returning
to normal values in the first week of their lives, after the
production of insulin by β cells normalized [3]. Later,
Kodama et al. [4] described another mode of inducing
insulin resistance in rats by substituting streptozotocin for
alloxan [4]. In this model, alloxan was administered to
Wistar rats of 2, 4, or 6 days of age. When they reached the
age of 60 days, all rats that had received alloxan on their
2nd  day of life showed slightly increased non-fasting
serum glucose, whereas those that had received the drug
on the 4th or 6th day of life showed significantly higher
plasma glucose levels than did the controls.
Unlike the rats treated with streptozotocin, those treated
with alloxan on the 4th or 6th day of life showed increased
longevity coupled with persistent hyperglycemia, since
insulin production by pancreatic β cells did not normal-
ize.
In a previous study we analyzed the model developed by
Kodama et al. [4] and observed that all male Wistar rats
which had received alloxan (200 mg/kg body weight) at 2
days old managed to recover from the glucose intolerance
on the 90th day [5], while other metabolic disorders, such
as high levels of circulating Free Fatty Acid (FFA), persisted
during the experimental period.
Regular physical activity has been proved to be efficient in
normalizing glucose homeostasis in diabetic patients, as
well as improving insulin sensitivity and glucose tolerance
[6-8]. Aerobic exercises are generally prescribed to patients
with type 2 diabetes [6,7,9]. Since there are limitations to
experimentation with humans, the use of animal models
is necessary when testing these strategies.
The aim of the present study was to analyze the effects of
a physical exercise programme, adjusted to the aerobic-
anaerobic transition, on glucose homeostasis in adult
Wistar rats treated with alloxan when newly born.
Methods
Animal treatment
The studies were carried out using newly born female Wis-
tar rats, kept at 25 ± 1°C and under a 12/12 h light-dark
cycle. The animals were fed on a special purified diet for
rodents prepared in our laboratory (following AIN-93G
[10]) and they were allowed water ad libitum. Food and
water intake as well as the body weight of all animals were
recorded weekly. All animal procedures complied with
the European Convention for the Protection of Vertebrate
Animals used for Experimental and other Scientific Pur-
poses of the Council of Europe, n 123, Strasbourg, 1985.
Administration of alloxan
On reaching the age of 6 days, 16 female rats were injected
intraperitoneally with alloxan monohydrate (Sigma-
Aldrich Inc., St Louis, MO, USA) dissolved in citrate buffer
0.01 M, pH 4.5 to a concentration of 250 mg/kg of body
weight. The animals were fasted for 16 h prior to drug
administration [4]. Sixteen rats of the same age injected
with the same volume of citrate buffer were used as con-
trols. All the experimental procedures were carried out as
originally proposed by Kodama et al [4], except that those
authors injected a lower dose of alloxan (200 mg/kg of
body weight). Previous studies in our laboratory [5]
showed that using alloxan 200 mg/kg of body weight
resulted in spontaneous recovery from glucose intoler-
ance in all rats after 90 days of experimentation.
Experimental groups
The animals (both controls and alloxan-treated) were ran-
domly divided into groups of 8 after weaning (28 days),
and were treated up to 120 days old as follows:
￿ Controls (C): no exercise programme;
￿ Trained Controls (TC): underwent a swimming training
programme;
￿ Alloxan (A): no exercise programme;
￿ Trained Alloxan (TA): underwent a swimming training
programme;
Glucose tolerance test (GTT)
All rats were fasted for 16 h when they reached the age of
28, 60, 90, and 120 days, then a glucose solution (200 g/BMC Endocrine Disorders 2008, 8:11 http://www.biomedcentral.com/1472-6823/8/11
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L) was administered via a catheter through the mouth into
the stomach at a dose of 2.0 g/kg of body weight. Blood
samples (25 μL) were then taken from a cut on the tip of
their tails to determine the levels of serum glucose at 0, 30,
60, and 120 min after glucose administration. In addition,
blood samples (75 μL) were obtained at 0 min to obtain
insulin levels in order to calculate the HOMA (Homeosta-
sis Model Assessment) insulin sensitivity index.
The levels of serum glucose were determined using the
glucose-oxidase colorimetric enzymatic method (Labor-
lab Kit, Guarulhos, São Paulo, Brazil), while levels of insu-
lin were measured by radioimmunoassay [11]. The blood
response to glucose during the GTT was evaluated based
on the total area under the curve of serum glucose (mM ×
120 min) [12].
Sensitivity to insulin
Peripheral insulin sensitivity was evaluated on days 28,
60, 90, and 120 based on the HOMA insulin sensitivity
index using the following equation: serum insulin (pmol/
L) × serum glucose mmol/L/22.5. Using this method,
higher HOMA indices denoted lower insulin sensitivity
[13].
Effort test
On the 28th day, all animals were subjected to an effort
trial to determine their individual exercise intensity neces-
sary to reach the aerobic/anaerobic metabolic transition,
following the Maximal Lactate Steady State protocol
(MLSS). This protocol was designed to detect the highest
blood lactate concentration at which the entrance of lac-
tate into the blood stream was counterbalanced by its
removal, maintaining a stable concentration during exer-
cises of constant intensity [14]. This has proved useful in
prescribing exercises to and determining the aerobic
capacity of humans [15], rats [16] and mice [17]. Our
research group has recently designed a MLSS protocol for
rats using swimming exercises [18], which was employed
in this study. In short, to determine the MLSS, a series of
25 min swimming exercises were performed, which sup-
ported increasing overloads in relation to body weight,
and were fixed in each series, with intervals of 48 h
between them. Blood samples were taken every 5 min,
from a cut on the tail tip, for lactate determination. The
blood lactate concentration representative of the MLSS
was considered at the highest overload in which there was
no variation in the blood lactate higher than 1.0 mmol/L
between 10 and 25 min of exercise [18,19]
Training Programmes
The animals were then subjected to a training programme
of 60 min/day, 5 days a week, over 12 weeks. The swim-
ming sessions were run in individual tanks with the estab-
lished relative overloads according to the rat's weight in
order to reach the individual aerobic/anaerobic metabolic
transition [18]. Every 30 days, new MLSS tests were con-
ducted to assign new overloads.
Statistics
Results are presented as means ± standard deviation and
were analyzed using the Students t-test and two-way
ANOVA followed by a Newman-Keuls test, where appro-
priate. Significance level was 5%.
Results
General parameters
Body weight, food and water intake are illustrated in Table
1. Groups TC [F1,24 = 9.33], A [F1,24 = 11.0] and TA [F1,24 =
11.35] displayed a smaller area under the body weight
curve than the controls. Rats in the TA [F1,18 = 16.66]
group consumed more food than the sedentary rats in
groups C and A. No difference in water intake was found
between the groups.
Prior-to-training evaluations
The results of the GTT on the 28th day are presented on
Figure 1A. Blood serum glucose levels in rats that received
alloxan were higher (A = 1309.0 ± 337.8, p < 0.05, student
t-test) than those of controls (C = 817.6 ± 59.6, p < 0.05
student t-test), as reflected by the increase in the area
under the serum glucose curves (mmol/L × 120 min) in
this group. There was no difference between the HOMA
insulin sensitivity indices of both groups (C = 22.7 ± 9.7
and A = 17.4 ± 13.2, p < 0.05, student t-test) when evalu-
ated on the 28th day (Figure 1B).
On the 28th day, all rats were subjected to the described
MLSS protocol. MLSS was performed using overloads of
5.0–7.5% of the rats' body weights. The animals did not
reach the MLSS using the same overloads within the same
group. Figure 2 represents the lactate concentration kinet-
ics during exercise for most animals in each group. In the
TC group, 25% of the animals reached the MLSS using
overloads of about 5% of their body weight, and their
mean lactate concentration was 7.3 ± 2.4 mmol/L; the
remaining 75% (Figure 2) reached the MLSS using over-
Table 1: Body weight, food intake and water intake.
Groups Body Weight Food intake Water intake
C 3648.7 ± 212.4 103.0 ± 11.0 127.9 ± 21.2
TC 3281.2 ± 212.0a 131.3 ± 8.7 148.6 ± 22.6
A 3258.3 ± 202.2b 106.9 ± 6.5 124.4 ± 5.2
TA 3093.2 ± 291.2c 137.6 ± 19.6c,d 156.9 ± 4.1
Areas under the body weight (grams × 12 weeks), food intake (food 
grams/100 g of body weight × 12 weeks) and water intake (water ml/
100 g of body weight × 12 weeks) curves of the animals.
Values are mean ± standard deviation, n = 8 animals per group.
C = Control; TC = Trained control; A = Alloxan e TA = Trained 
alloxan a = C vs TC; b = C vs A; c = C vs TA; d = A vs TABMC Endocrine Disorders 2008, 8:11 http://www.biomedcentral.com/1472-6823/8/11
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Area under serum glucose curve during GTT and HOMA – 28 days Figure 1
Area under serum glucose curve during GTT and HOMA – 28 days. A- Area under serum glucose curve during GTT 
(mmol/L × 120 min) of the animals after weaning (28 days of age – C and A). B- HOMA* insulin sensitivity index after weaning 
(28 days of age – C and A). Values showed as mean ± standard deviation, n = 8 animals per group. C = Control; A = Alloxan. 
*homeostasis assessment model. # diference.
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Effort test Figure 2
Effort test. Blood lactate concentrations (mmol/L) during the effort tests for determining MLSS of most 28-days-old rats of 
each group.
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loads of 6.5% of their body weight and their mean lactate
concentration was 6.0 ± 2.6 mmol/L. In the TA group,
50% of the animals (Figure 2) reached the MLSS using
5.5% of body weight overloads and their mean lactate
concentration was 3.8 ± 0.7 mmol/L, while 33.3% of the
animals reached the MLSS with 6.0% of body weight over-
loads and their mean lactate concentration was 6.5 ± 0.6
mmol/L, and 16.7% of the animals reached the MLSS
using loads 6.5% of their body weight, with a mean lactate
concentration of 10.4 ± 0.6 mmol/L.
During training evaluations
There were no differences between the HOMA indices of
the groups at 60 days old (C = 17.7 ± 3.6, TC = 19.8 ± 4.7;
A = 33.3 ± 19.6 and TA = 32.4 ± 10.6). However, on the
90th day, TC animals were more insulin sensitive than the
other groups (TC = 19.8 ± 2.6 [F1,19 = 6.96]; C = 28.7 ± 4.5;
A = 30.8 ± 4.8 and TA = 31.2 ± 5.5), and on the 120th day,
no statistical differences between the groups regarding
insulin sensitivity were observed (C = 19.4 ± 4.3; TC =
17.4 ± 6.4; A = 19.4 ± 6.4 and TA = 18.6 ± 2.6).
At 60 days old, groups A (1043.4 ± 103.1 [F1,26 = 61.97)
and TA (1131.2 ± 189.7 [F1,26 = 61.97]) showed high
serum glucose concentrations based on the area under the
serum glucose curve during the GTT, compared with the
controls (C = 774.9 ± 69.9 and TC = 756.9 ± 38.9). On the
other hand, at 90 days old (C = 735.9 ± 64.1; TC = 670.9
± 40.8; A = 1162.9 ± 202.9 and TA = 1017.4 ± 129.0 [F1,26
= 5.55]) and 120 days old (C = 755.8 ± 64.5; TC = 640.7
± 106.4; A = 1299.4 ± 198.3 and TA 972.2 ± 135.0) the
area under the serum glucose curve in the TA [F1,26 = 4.43]
group decreased compared with that in group A (Figure
4).
HOMA Figure 3
HOMA. HOMA* insulin sensitivity index of 60th, 90th and 120th days of age (C, TC, A and TA). Values showed as mean ± 
standard deviation, n = 8 animals per group. C = Control; TC = Trained control; A = Alloxan e TA = Trained alloxan. a = C vs 
TC; e = TC vs TA; *homeostasis assessment model.
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Discussion
The aim of the present study was to analyze the effects of
a physical exercise programme, adjusted to the aerobic-
anaerobic transition, on the glucose homeostasis of adult
Wistar rats treated with alloxan when newly born.
Our results demonstrated that the sedentary group C
showed a greater increase in body weight than did groups
A, TA, and TC. Although TA rats had the highest food
intake, they did not assimilate this energy as body mass.
It was previously shown that animals receiving streptozo-
tocin in their first days of life had compromised secretory
insulin capacity just after drug administration [20]. It is
probable that a similar reduction in insulin production
took place in this study when the rats were injected with
alloxan, because animals in this group demonstrated a
low increase in body weight. Reports from other studies
have shown that young animals or humans with reduced
insulin demonstrated body weight gain impairment and a
delay in the process of growth and physical maturation
[21].
Obesity is one of the main causes of type 2 diabetes. In the
present study, the training programme reduced body
weight gain. These results are in agreement with other
studies [22] which showed that animals subjected to run-
ning sessions gained 24% less body weight than sedentary
controls following 6 weeks of physical training. The liter-
ature also states that physical activity on a regular basis
and restrictions in body weight gain reduce the incidence
of type 2 diabetes in patients with glucose intolerance
[23].
The GTT on the 28th day illustrated that the animals
exhibited an adequate response to neonatal alloxan
administration, via a bigger area under the serum glucose
curve than the controls. In the subsequent evaluations at
60, 90 and 120 days old, group A rats remained glucose
intolerant.
In another study carried out in our laboratory, Oliveira et
al (2005) observed that rats receiving alloxan (200 mg/kg
of body weight) at 2 days old showed spontaneous
improvement in glucose tolerance [5]. In the present
study, the observed high steady blood serum glucose lev-
els in group A animals was probably due to the later age at
which the animals received alloxan (6 days) and also
because of the higher dosage used (250 mg/kg). Kodama
et al. (1993) showed that when alloxan was administered
Area under serum glucose curve during GTT Figure 4
Area under serum glucose curve during GTT. Area under serum glucose curves during GTT (mmol/L × 120 min) of 
60th, 90th and 120th days of age (C, TC, A and TA). Values showed as mean ± standard deviation, n = 8 animals per group. C 
= Control; TC = Trained control; A = Alloxan e TA = Trained alloxan. b = C vs A; c = C vs TA; d = A vs TA; e = TC vs TA.
AREA UNDER GLUCOSE CURVE DURING GTT
0
200
400
600
800
1000
1200
1400
1600
CT CAA T
Groups
m
m
o
l
/
L
 
x
 
1
2
0
 
m
i
n
60
90
120
  Days
   60     90    120     60      90    120  60    90     120 60    90     120
b
b c,e
c,d,e
c,d,e
bBMC Endocrine Disorders 2008, 8:11 http://www.biomedcentral.com/1472-6823/8/11
Page 8 of 9
(page number not for citation purposes)
to newly born rats, the earlier the drug was administered
the less severe the blood glucose derangement was in later
life [4].
According to the American Diabetes Association, patients
who present with glucose intolerance and/or altered fast-
ing blood glucose levels are prone to developing type 2
diabetes, and are thus candidates for interventions in
order to monitor and control the onset of the disease [24].
The American Diabetes Association also claims that oral
glucose tolerance tests and evaluation of fasting blood
glucose levels are the best parameters to track the develop-
ment of type 2 diabetes.
The United Kingdom Prospective Diabetes Study (1995)
demonstrated that β cell dysfunction in humans starts at
around 10–12 years old before type 2 diabetes develops,
therefore offering a long interval for the initiation of pro-
phylactic interventions [25]. The non-exercised alloxan
rats in the present study remained in this pre-diabetic con-
dition throughout the experiment, illustrating the useful-
ness of this model in designing intervention strategies in
cases of type 2 diabetes in future studies, since there are
obstacles to experimentation with humans.
Identification of the MLSS was successfully employed to
evaluate the aerobic capacity of the experimental animals
[18]. This protocol also enabled the quantification of their
individual aerobic capacity. In the present study, the pro-
cedures employed to induce glucose intolerance caused a
reduction in blood lactate levels in most TA animals at the
MLSS compared with controls, even though the overloads
during the MLSS were the same for both groups.
Randle, in studies using the hearts and diaphragms of rats
suggested the existence of a mechanism known as the glu-
cose-fatty acid cycle. He observed that increases in FFA
plasma levels were followed by decreases in glucose
uptake and oxidation by these organs [26]. In general,
type 2 diabetes leads to an increase in the circulating levels
of FFA, which are used up by peripheral tissues, such as
the skeletal muscles, saving glycogen [27]. This may have
led to reduced glucose utilization, thus resulting in a
lower production of lactate in TA rats.
Our results show that when the animals were 90 days old,
i.e. 60 days after the start of physical training, the swim-
ming sessions effectively reduced the area under the
serum glucose curve of the GTT in TA rats, thus demon-
strating a significant recovery in tolerance to glucose (Fig-
ure 4). A similar recovery was observed in TA rats at 120
days old. The reduction in serum glucose levels in the TA
group could have been mediated by an increase in the
numbers of glucose transporters [28]. A previous study
conducted in our laboratory demonstrated that swim-
ming sessions in the aerobic/anaerobic transition also
attenuated glucose intolerance in type 1 diabetes rat mod-
els [29].
Knowing the exact moment and how physical activity can
contribute to counteracting or preventing type 2 diabetes
will be useful in encouraging diabetic patients to take part
in physical activity on a regular basis. Page et al. (1992)
showed that 6 months of continued regular exercise was
not enough time for patients to assimilate this into their
life habits [30].
Conclusion
The neonatal administration of alloxan induced persistent
glucose intolerance, which was counteracted by physical
training in the aerobic/anaerobic metabolic transition.
The use of the HOMA index as an indicator of insulin
resistance proved inefficient in detecting differences
among the experimental groups in most cases. Thus com-
plementary studies using alternative procedures are neces-
sary in order to obtain a more comprehensive
characterization of this model.
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